Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Goel

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Molecular Cancer Therapeutics|March 12, 2020
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with <i>KRAS</i>-Mutated Colorectal CancerSanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, et al.
Journal of Racial and Ethnic Health Disparities|July 11, 2023
Differences in Breast Cancers Among American Indian/Alaska Native and non-Hispanic Whites in the USAAnu G Gaba, Li Cao, Rebecca J Renfrew, et al.
Investigational New Drugs|January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancersSanjay Goel, Kavita Desai, Sirisha Karri, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumorsVincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Clinical Breast Cancer|January 3, 2024
The Impact of Medicaid Expansion Under the Affordable Care Act on the Gap Between American Indians and Whites in Breast Cancer Management and PrognosisAnu G Gaba, Li Cao, Rebecca J Renfrew, et al.
Disease Markers|June 23, 2011
Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot studyVivek Kumar, Chandra Shekhar Yadav, Sudip Kumar Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignanciesKyriakos P Papadopoulos, Sanjay Goel, Murali Beeram, et al.
Investigational New Drugs|October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trialsAudrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
American Journal of Clinical Oncology|October 24, 2002
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignanciesSanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Molecular Cancer Therapeutics|March 12, 2020
Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with <i>KRAS</i>-Mutated Colorectal CancerSanjay Goel, Allyson J Ocean, Ruwan Y Parakrama, et al.
Journal of Racial and Ethnic Health Disparities|July 11, 2023
Differences in Breast Cancers Among American Indian/Alaska Native and non-Hispanic Whites in the USAAnu G Gaba, Li Cao, Rebecca J Renfrew, et al.
Investigational New Drugs|January 2, 2007
Pharmacokinetic and safety study of weekly irinotecan and oral capecitabine in patients with advanced solid cancersSanjay Goel, Kavita Desai, Sirisha Karri, et al.
Cancer Chemotherapy and Pharmacology|November 5, 2017
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumorsVincent A de Weger, Sanjay Goel, Roger von Moos, et al.
Clinical Breast Cancer|January 3, 2024
The Impact of Medicaid Expansion Under the Affordable Care Act on the Gap Between American Indians and Whites in Breast Cancer Management and PrognosisAnu G Gaba, Li Cao, Rebecca J Renfrew, et al.
Disease Markers|June 23, 2011
Association of GSTM1 and GSTT1 polymorphism with lipid peroxidation in benign prostate hyperplasia and prostate cancer: a pilot studyVivek Kumar, Chandra Shekhar Yadav, Sudip Kumar Datta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2008
A phase 1 open-label, accelerated dose-escalation study of the hypoxia-activated prodrug AQ4N in patients with advanced malignanciesKyriakos P Papadopoulos, Sanjay Goel, Murali Beeram, et al.
Investigational New Drugs|October 14, 2018
Survival outcome and prognostic model of patients with colorectal cancer on phase 1 trialsAudrey E Kam, Gopichand Pendurti, Umang H Shah, et al.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
American Journal of Clinical Oncology|October 24, 2002
Phase I clinical trial of irinotecan with oral capecitabine in patients with gastrointestinal and other solid malignanciesSanjay Goel, Minaxi Jhawer, Lakshmi Rajdev, et al.
Pageof 19